See Also: Bretylium tosylate in dextrose 5 per cent in plastic container(health)
Bretylium tosylate in dextrose 5 per cent(health)
Bretylium tosylate in plastic container(health)
bretylium tosylate(medicine)
Bretylium tosylate(health)
Travasol 2.75 per cent sulfite free with electrolytes in dextrose 5 per cent in plastic container(health)
Travasol 2.75 per cent sulfite free with electrolytes in dextrose 25 per cent in plastic container(health)
Travasol 4.25 per cent sulfite free with electrolytes in dextrose 10 per cent in plastic container(health)
Travasol 4.25 per cent sulfite free with electrolytes in dextrose 15 per cent in plastic container(health)
Travasol 2.75 per cent sulfite free with electrolytes in dextrose 15 per cent in plastic container(health)

Bretylium tosylate in dextrose 5 per cent in plastic container (health) and postpoliomyelitis syndrome (medicine)


Bretylium tosylate in dextrose 5 per cent in plastic container (health)


Bretylium tosylate in dextrose 5 per cent in plastic container is a prescription or over-the-counter drug which is (or once was) legal in the United States and possibly in Other countries. Active ingredient(s): bretylium tosylate.





postpoliomyelitis syndrome (medicine)


postpoliomyelitis syndrome
<syndrome> A "postpolio" syndrome characterised by new neuromuscular symptoms, including muscle weakness, that develops years after recovery from poliomyelitis. The symptoms may vary from simple nonprogressive deterioration of function, with joint pain, fatigue, and subsequent stabilization, to atypical forms of spinal muscular dystrophy. The new, slowly progressive muscle weakness may occur in muscles that were previously affected by polio and recovered or in muscles that were clinically unaffected by the acute disease.